Impact of downstream purification process and AAV serotype on protein-impurity clearance.

Béard N, Rouby G, Luc C, Thomas C, Vanthournout K, Dubreuil G, Loukili Z, Santambien P, Carapito C, Fragnoud R.

Open source

DOI
10.1016/j.omta.2026.201752
Published
2026-05-06
Container
Mol Ther Adv
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omta.2026.201752,
  title = {Impact of downstream purification process and AAV serotype on protein-impurity clearance.},
  author = {Béard N and  Rouby G and  Luc C and  Thomas C and  Vanthournout K and  Dubreuil G and  Loukili Z and  Santambien P and  Carapito C and  Fragnoud R.},
  year = {2026},
  journal = {Mol Ther Adv},
  doi = {10.1016/j.omta.2026.201752},
  url = {https://doi.org/10.1016/j.omta.2026.201752}
}

RIS

TY  - JOUR
TI  - Impact of downstream purification process and AAV serotype on protein-impurity clearance.
AU  - Béard N
AU  -  Rouby G
AU  -  Luc C
AU  -  Thomas C
AU  -  Vanthournout K
AU  -  Dubreuil G
AU  -  Loukili Z
AU  -  Santambien P
AU  -  Carapito C
AU  -  Fragnoud R.
PY  - 2026
JO  - Mol Ther Adv
DO  - 10.1016/j.omta.2026.201752
UR  - https://doi.org/10.1016/j.omta.2026.201752
ER  - 

APA

N, B., G, R., C, L., C, T., K, V., G, D., Z, L., P, S., C, C., & R., F. (2026). Impact of downstream purification process and AAV serotype on protein-impurity clearance.. Mol Ther Adv. https://doi.org/10.1016/j.omta.2026.201752

Source records